Skip to main content
SpringerLink
Log in

Social media: pharmacovigilance early warning system?

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Notes

  1. lisdexamfetamine and Raynaud's phenomenon; olmesartan and spru-like enteropathy; methylphenidate and priaprism; topical econazole and increased INR; dabigatran etexilate [Pradaxa] and angioedema; dronedarone and vasculitis; hydroxyzine and serious injection site reactions; ziprasidone and DRESS; dimethyl fumarate [Tecfidera] and progressive multifocal leukoencephalopathy; Banana Boat Sunscreen Spray and flammability resulting in serious skin burns

Reference

  • Pierce CE, et al. Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts. Drug Safety : 2 Jan 2017. Available from: URL: http://dx.doi.org/10.1007/s40264-016-0491-0

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Social media: pharmacovigilance early warning system?. Reactions Weekly 1635, 10 (2017). https://doi.org/10.1007/s40278-017-25259-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-017-25259-5

Search

Navigation